Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Deep Learning on Hester Davis Scores for Inpatient Fall Prediction
Salehinejad, Hojjat , Rojas, Ricky, Iheasirim, Kingsley, Yousufuddin, Mohammed , Rojas, Ricky, Borah, Bijan J.

2025 IEEE Symposium on Computational Intelligence in Health and Medicine (CIHM) | April 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: 1-6

10.1109/cihm64979.2025.10969483 Get It

Deep Learning Model for Histologic Diagnosis of Dysplastic Barrett's Esophagus: Multisite Cohort External Validation
Codipilly, Don C. , Faghani, Shahriar , Vogelsang, David C. , Erickson, Bradley J. , Garg, Nikita , Lewis, Jason , Leggett, Cadman L. , Konda, Vani J. , Diffalha, Sameer Al , Peter, Shajan, Brinkerhoff, Brian , Wong, Mary , Otaki, Fouad , Katzka, David A. , Wani, Sachin , Shaheen, Nicholas J. , Iyer, Prasad G. , Codipilly, Don Chamil , Vogelsang, David, Erickson, Bradley J , Hagen, Catherine E , Leggett, Cadman L , Konda, Vani , Wong, Mary , Otaki, Fouad , Katzka, D A , Faghani, Shahriar , Hagen, Catherine E. , Patil, Pallavi

American Journal of Gastroenterology | April 23, 2025 | Volume: 121 | Issue: 4 | Pages: 863-870

10.14309/ajg.0000000000003495 | PMID 40267276 Get It

INTRODUCTION: The risk of progression to esophageal adenocarcinoma in Barrett's esophagus (BE) increases with advancing degrees of dysplasia. There is a critical need to improve the diagnosis of BE dysplasia, given substantial interobserver variability and overcalls of dysplasia during manual community pathologist reads. We aimed to externally validate a previously cross-validated BE dysplasia diagnosis deep learning model (BEDDLM) that predicts dysplasia grade on whole slide images (WSIs). METHODS: We digitized nondysplastic BE (NDBE), low-grade (LGD), and high-grade dysplasia (HGD) histology slides from 3 external academic centers. A consensus read by 2 expert study pathologists was used as the criterion standard. Slide stain characteristics were normalized using cycle-generative adversarial networks. WSIs were assessed by BEDDLM using an ensemble approach, combining a “You Only Look Once” model followed by a ResNet101 classifier model. RESULTS: We included 489 WSIs. Consensus histopathology revealed 232 NDBE, 117 LGD, and 140 HGD WSIs. The mean age (SD) was 66.9 (11.4) years; 413 (84.7%) were men. Using the BEDDLM ensemble model, sensitivity and specificity for NDBE were 73.3% (95% confidence interval [CI]: 67.09%–78.85%) and 93.4% (95% CI: 89.62%–96.10%); for LGD, 84.6% (95% CI: 76.78%–90.62%) and 80.6% (95% CI: 76.26%–84.54%); and for HGD, 80.7% (95% CI: 73.19%–86.89%) and 94.8% (95% CI: 91.97%–96.91%), respectively. The F1 score was 0.81, 0 0.69, and 0.83 for NDBE, LGD, and HGD, respectively. DISCUSSION: Our externally validated deep learning model demonstrates substantial accuracy for the diagnosis of BE dysplasia grade on WSIs.
Artificial intelligence in sleep medicine: assessing the diagnostic precision of ChatGPT-4
Patel, Anshum , Cheung, Joseph , Cheung, Joseph

Journal of Clinical Sleep Medicine | April 23, 2025 | Volume: 21 | Issue: 9 | Pages: 1511-1517

10.5664/jcsm.11732 | PMID 40265240 Get It

Aβ 42/40 and p-tau 181 as disease biomarkers in atypical Alzheimer's disease
Singh, Neha Atulkumar , Graff‐Radford, Jonathan , Li, Danni , Mielke, Michelle M. , Machulda, Mary M. , Schwarz, Christopher G. , Senjem, Matthew L. , Jack, Clifford R. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer L. , Singh, Neha Atulkumar , Jack, Clifford R , Schwarz, Christopher G , Mielke, Michelle M , Senjem, Matthew L , Machulda, Mary M

Journal of Alzheimer’s Disease | April 23, 2025 | Volume: 105 | Issue: 3 | Pages: 923-931

10.1177/13872877251333450 | PMID 40267266 Get It

Background Studies suggest that plasma Alzheimer's disease (AD) biomarkers may aid in the overall diagnosis of AD, but their utility among patients with atypical clinical presentations of AD are unknown. Objective The main objective of this study was to determine the relationship between amyloid-β (Aβ) and tau plasma biomarkers and PET measures of both Aβ and tau in atypical AD. The secondary objective was to determine if plasma biomarkers could differentiate patients with different atypical AD phenotypes and whether they were related to measures of disease severity. Methods We assessed whether plasma p-tau 181 and Aβ 42/40 were associated with Aβ and tau PET uptake, clinical phenotype and severity in 77 patients with PET biomarker-confirmed atypical AD. Results Plasma Aβ 42/40 ratio showed positive associations with tau PET uptake, with higher (more normal) Aβ 42/40 ratio associated with higher tau uptake; the ratio was not associated with Aβ PET. No associations were noted with plasma p-tau 181. Plasma Aβ 42/40 ratio and p-tau 181 concentrations were not associated with AD phenotype or cognitive severity. Conclusion Plasma Aβ 42/40 ratio and p-tau 181 concentrations are not associated with amyloid or tau PET or with clinical severity among individuals presenting with atypical AD.
Childhood Dementia: The Collective Impact and the Urgent Need for Greater Awareness and Action
Elvidge, Kristina L. , Farrar, Michelle A. , Kava, Maina , Johnson, Alexandra , Wilmshurst, Jo M. , Smith, Nicholas , Patterson, Marc C. , Wilmshurst, Jo M , Christodoulou, John , Jones, Simon , Zuberi, Sameer M.

Journal of Child Neurology | April 23, 2025 | Volume: 40 | Issue: 7 | Pages: 501-503

10.1177/08830738251331359 | PMID 40267279 Get It

Ovarian juvenile granulosa cell tumor: A report from the International Ovarian and Testicular Stromal Tumor and International Pleuropulmonary Blastoma/DICER1 Registries
Harris, Anne K. , Nelson, Alexander T. , Watson, Dave , Mallinger, Paige, Stering, Allen I., Snyder, Stacy L., Levy, Carolyn Fein , Kamihara, Junne , Herzog, Cynthia E. , Lagmay, Joanne , Foresto, Steve, Young, Robert H. , Dehner, Louis P. , Tadavarthy, Anil K., Stall, Jennifer N., Billmire, Deborah F., Schneider, Dominik T. , Schultz, Kris Ann P. , Kamihara, Junne , Chen, Kenneth S , Devins, Kyle M , Schneider, Dominik T , Schultz, Kris Ann P , Levy, Carolyn Fein , Harris, Anne K , Messinger, Yoav H. , Frazier, A Lindsay , Chen, Kenneth , Devins, Kyle M. , Hill, Dana Ashley

Cancer | April 23, 2025 | Volume: 131 | Issue: 9 | Pages: No page available

10.1002/cncr.35862 | PMID 40267023 Get It

AbstractBackgroundOvarian juvenile granulosa cell tumors (juvGCT) are rare sex cord‐stromal tumors that occur primarily in children and adolescents. This study summarizes the clinical presentation and outcomes of patients with juvGCT.MethodsPatients were enrolled in the International Ovarian and Testicular Stromal Tumor and/or International Pleuropulmonary Blastoma/DICER1 Registries. Available medical records were abstracted, and pathology was centrally reviewed. Surgical staging was classified using the 2014 International Federation of Gynecology and Obstetrics (FIGO) criteria.ResultsIn total, 70 patients with juvGCT enrolled and were diagnosed between 2001 and 2024; most patients (81%, 57 of 70) presented with FIGO stage I disease. Adjuvant chemotherapy was given in 30% (21 of 70); all regimens were platinum‐based. Three‐year event‐free survival among patients with stage IA tumors was 80.2% (95% confidence interval [CI], 62.4%–100.0%), IC1 was 87.4 (95% CI, 72.4%–100.0%), IC2‐IC3 was 63.6% (95% CI, 40.7%–99.5%), and II‐IV was 48% (95% CI, 24.6%–93.8%). Of the patients with recurrent juvGCT with known mitotic index (MI), all had MI greater than 19 mitoses per 10 high power fields (HPF) at diagnosis.ConclusionOutcomes were worse for patients with FIGO stage ≥IC2 disease and for tumors with >19 mitoses per 10 HPF. Given the prognostic significance of MI, the authors strongly recommend the assessment of MI for all juvGCTs. More information about tumor biology is critical to identify which patients may benefit from adjuvant chemotherapy and to facilitate the development of novel therapies.
Single cell resolution of an epigenetic signature of persister tumor cells
Dumbravă, Mihai , Sandoval, Letícia , Mazzone, Amelia , Aalam, Syed Mohammed Musheer , Ritting, Megan L. , Hou, Xiaonan , Xie, Yiwen , Harrington, Shariska P. , Kaufmann, Scott H. , Weroha, S. John , Kaufmann, Scott H , Dumbrava, Mihai , Mazzone, Amelia , Musheer Aalam, Syed Mohammed , Ismail, Wazim Mohammed , Kannan, Nagarajan , Gaspar‐Maia, Alexandre

No container title available | April 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.16.649175 Get It

Abstract Cancer can recur when a subset of tumor cells, denoted here as persister cells, are able to survive therapy and re-enter the cell cycle. The precise mechanisms that confer the persister state and whether it is characteristic of a subgroup of cells or arises from multiple cellular lineages remain poorly understood. We hypothesize that an epigenetic signature underlies the drug-tolerant persister state, characterized by transcriptional and chromatin accessibility changes that promote survival of residual cancer following chemotherapy. To identify clinically relevant features of persister cells in untreated tumors and residual disease, we performed single-cell multiomic profiling (snRNA+snATAC) on a cohort of non-malignant fallopian tube, treatment-naïve, and neoadjuvant chemotherapy (NACT)-treated high-grade serous ovarian cancer (HGSOC) samples. We identified differences in gene expression and open chromatin between naïve and residual patient tumors following chemotherapy. Although only a small proportion of the differentially expressed genes enriched in residual HGSOC overlapped with established gene sets for chemo-response and patient prognosis, the epigenomic analysis revealed activity of several DNA-binding factors that are both enriched upon chemotherapy and also high in resistant tumors prior to treatment. From this analysis, we identified an epigenetic signature that precedes expression and defines the persister state. This epigenetic signature also correlated with chemotherapy sensitivity and resistance using patient-derived xenograft models of HGSOC. Gene regulatory networks driven by the persister signature are involved in the activation of oncogenic pathways, including changes to the cell cycle promoting quiescence and stress response. Further study of the persister cells identified by this epigenetic signature may increase understanding of the mechanisms underlying persister cell survival and reveal new vulnerabilities that could be exploited to delay or prevent cancer recurrence.
TNFα-mediated subcellular heterogeneity of succinate dehydrogenase activity in human airway smooth muscle cells
Bhat, Sanjana Mahadev , Creighton, Claire C., Sieck, Gary C. , Mahadev Bhat, Sanjana , Creighton, Claire Catherine, Sieck, Gary , Creighton, Claire

American Journal of Physiology-Lung Cellular and Molecular Physiology | April 23, 2025 | Volume: 328 | Issue: 6 | Pages: L792-L808

10.1152/ajplung.00396.2024 | PMID 40266735 Get It

Mitochondria show context-specific heterogeneity in their morphometry. Previously, we reported that acute TNFα exposure increased O 2 consumption rate (OCR) and mitochondrial volume density, but decreased OCR per mitochondrion. TNFα also altered mitochondrial distribution and motility. To assess TNFα-mediated subcellular mitochondrial structural and functional heterogeneity, we used a confocal-based quantitative histochemical technique to determine the maximum velocity of succinate dehydrogenase reaction. Our findings highlight that mitochondria within cells exhibit functional heterogeneity, which is disrupted during inflammation.
Spatially convergent fMRI signatures of diabetes and male sex identify genetic vulnerabilities to accelerated brain aging
Chesebro, Anthony G. , Rohm, Luna R., Antal, Botond , Weistuch, Corey , Strey, Helmut H. , Ratai, Eva‐Maria , Mujica‐Parodi, Lilianne R. , Mujica-Parodi, Lilianne R , Jones, David T.

No container title available | April 23, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.04.14.648801 Get It

Abstract Age-related cognitive decline results from complex interactions between neuroendocrine and neurometabolic processes that undergo lifelong degredation, yet the mechanisms underlying these interactions remain poorly understood. This study examined the effects of diabetes and sex on functional brain networks across aging through analysis of two large cohorts (N=1,621 total) using both 3T and 7T functional MRI, complemented by spatial transcriptomic data from over 14,000 genes from six post-mortem brains. Four networks— cingulo-opercular, default mode, salience, and lateral somatomotor—exhibited significant functional decline in both individuals with diabetes and independently in males. Gene expression analysis of vulnerable networks revealed significant overexpression of insulin-dependent glucose transporters, dopaminergic and GABAergic synaptic genes, and VEGFA-VEGFR2 pathway components. These findings suggest functionally-specific circuit vulnerability to metabolic and hormonal dysregulation, potentially offering targets for early intervention before irreversible neurodegeneration occurs.